Pregnancy Related Clinical Trial
Official title:
The Effect of Iodine Intakes on Maternal and Infant Health and the Study of Iodine RNI for Different Stages of Pregnancy
This study determined the effects of different iodine intake on the maternal and infant
health and provide evidence for studying the RNI and UL of iodine in pregnant women.
1. The study of effect on mothers and their infants of the lack of iodine at different
gestation in adequate iodine area.
The purpose of this study was to detect the maternal thyroid function, growth and
neuropsychological development of infants in different pregnancy women with diverse
iodine intake levels, and to make a clear evaluation for the influence of iodine
deficiency during different pregnancy by following up iodine suitable early pregnancy
women and mild iodine deficient three pregnancy women as well as their infants.
2. The study of recommended iodine intake (RNI) for healthy pregnant women in three
pregnancy.
Different pregnancy women with different iodine intake levels were recruited and carried
out iodine balance experiment in the case of not interfering with their diet. In
addition, the iodine intake of the pregnant women when they reached "zero iodine
balance" was calculated, that was EAR of iodine in pregnant women. In conclusion, the
iodine balance experiment in pregnant women at different pregnancy improved the sample
collection methods and evaluation criteria and was more scientific and reasonable than
the classic iodine balance experiment.
3. The study of effect of different levels of high iodine exposure on pregnant women,
delivery women and their infants.
In this study, we made a prospective study of the early pregnancy women and their infants
exposed to different high iodine levels in high water iodine areas. At first we defined the
effects of long-term iodine excess exposure on the health of the mother and the infants by
combining with the reference index of the normal value of the thyroid function in different
maternal and postpartum periods, the level of growth and development of the offspring and the
assessment of the level of neuropsychological development. Furthermore the harmful effects of
different high levels of iodine exposure on pregnant women was synthetically analyzed. This
study obtained the safe intake level of iodine for pregnant women and provided scientific
basis for the formulation of iodine UL in pregnant women in China.
1. The relationship between iodine deficiency during pregnancy and maternal offspring health
1. Screening of pregnant women with iodine deficiency:
A prevalence survey of pregnant women was conducted in iodine-sufficient area, combined
with the results of single spot urinary concentration, 24h urinary iodine concentration
and thyroglobulin level, screening out pregnant women with iodine deficiency during
first, second and third trimester of pregnancy. There are 60 pregnant women in each
group. At the same time, 60 pregnant women with iodine-sufficient during early pregnancy
were selected, and the total number of the four groups is 240.
2. Effects of iodine deficiency on pregnant women during different pregnancy:
Pregnant women with iodine deficiency were gived nutritional guidance, and were advised
to take iodine supplements. Follow-up with regularly collecting fasting venous blood,
dried whole blood and single spot urine was conducted, in order to dynamically grasp the
iodine nutritional status and thyroid function of pregnant women during different
pregnancy, and clarify the influence of iodine deficiency on pregnant women in each
group.
3. Effects of iodine deficiency on offspring during different pregnancy:
The offspring of follow-up pregnant women were observed, collecting the heel blood at
birth for measuring TSH, and performing physical examination. Assessment of
neuropsychological development in offspring for two years after delivery was performed ,
in order to clarify the effects of iodine deficiency on the neuropsychological
development of offspring in each group.
4. Statistical analysis:
Normally distributed variables were reported as the mean ± standard deviation, comparison
between groups were analyzed with the use of t-test or analysis of variance (ANOVA), and
Pearson linear correlation was used for correlation analysis; Urinary iodine level is
lognormal distribution, so it was converted into logarithmic form and then analyzed.
Non-normally distributed variables were presented as median and interquartile range. The
Wilcoxon rank sum test was used for comparison between groups, and correlation analysis was
performed using the Spearman rank correlation test. The chi-squared test was adopted for the
comparison of enumeration data. P values below 0.05 was considered statistically significant.
2. Study the RNI of iodine on pregnant women during different pregnancy:
1. Screening of pregnant women during different pregnancy:
A prevalence survey of pregnant women was conducted in iodine-sufficient area, based on
24h urinary iodine concentration, thyroglobulin level, related health check and medical
history query results, screening out pregnant women who meet the requirements of this
study during first, second and third trimester of pregnancy. Each group has 20 pregnant
women, and the total number is 60.
2. Reasearch of the iodine EAR of pregnant women during different pregnancy:
Iodine balance studies were performed on healthy pregnant women during first, second and
third trimester of pregnancy to evaluate the daily iodine intake and excretion,
including collecting and testing 24h dietary iodine intake, 24h urinary iodine and fecal
iodine excretion of subjects. The daily respiratory iodine intake and excretion of
subjects was assessed by measuring the iodine content in the air and exhaled breath. In
addition, according to the positive correlation between iodine balance value and iodine
intake, a scatter plot was drawn and curve fitting was performed. According to the
results of iodine balance experiment, the iodine balance regression curves of first,
second and third trimester of pregnancy were established , in order to determine the
level of iodine intake when the pregnant women reach the iodine balance, which is the
estimated average requirement (EAR) of pregnant women during different pregnancy.
3. Research of iodine RNI on pregnant women during different pregnancy:
Based on the obtained EAR values of iodine for different pregnancy and the 20% coefficient of
variation (CV), according to the formula: RNI=EAR+2CV=1.4EAR, the iodine RNI values of
pregnant women in different gestation were derived.
3. Study on the relationship between iodine excess and maternal offspring health and iodine
UL of pregnant women
1. Prospective study:
Pregnant women during early pregnancy who were exposed to different excessive water
iodine intake were enrolled in a large-scale epidemiological prospective study, in order
to assess the levels of iodine intake by collecting and testing random urinary iodine
and 24h urinary iodine levels, and to detect the thyroid function indicators under
different iodine intake levels to evaluate the health effects and harms of different
high iodine intake on pregnant women. At the same time, the growth and development of
the offspring and the level of neuropsychological development were evaluated to
determine the long-term iodine excess exposure to the health of pregnant women and
offspring.
2. Discussion on iodine UL of pregnant women:
According to the urinary iodine level during pregnancy, the subjects were divided into
groups with different iodine intakes, with the TSH abnormal rate of pregnant women > 5%
and the increase of FT3/FT4 as the end point, comprehensively determining the harmful
effects of different iodine intake on pregnant women and offspring, analyzing the iodine
safety intake level suitabled for pregnant women, and exploring the iodine UL of
pregnant women.
3. Statistical methods:
Epi-data was used to enter survey data. Univariate statistical analysis was used to analyze
the differences in evaluation indicators between different iodine intake levels..
Multivariate statistical analysis methods were used to analyze the safety of each iodine
intake level under multiple factors.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05017974 -
Research on Improving Sleep During Pregnancy
|
N/A | |
Completed |
NCT03284515 -
Vaccination In Pregnancy Gene Signature: VIP Signature Study
|
||
Recruiting |
NCT05969795 -
Comparison of Live Birth Rate in Natural Cycle Single Euploid FET Versus Without Luteal Phase Support
|
Phase 1 | |
Recruiting |
NCT06051201 -
Innovation for Small-scale Experiments: ReceptIVFity Test
|
N/A | |
Recruiting |
NCT04828382 -
Prospective Study of Pregnancy in Women With Cystic Fibrosis
|
||
Enrolling by invitation |
NCT04527926 -
STEPuP: Prenatal Provider Education and Training to Improve Medication-assisted Treatment Use During Pregnancy
|
N/A | |
Recruiting |
NCT04278651 -
Early Antenatal Support for Iron Deficiency Anemia
|
Phase 4 | |
Recruiting |
NCT04405700 -
Measuring Adverse Pregnancy and Newborn Congenital Outcomes
|
||
Recruiting |
NCT06258902 -
Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation
|
||
Completed |
NCT05487196 -
Effectiveness of Clonidine, Dexmedetomidine, and Fentanyl Adjuncts for Labor Epidural Analgesia
|
Phase 2 | |
Completed |
NCT03750968 -
Lutein & Zeaxanthin in Pregnancy - Carotenoid Supplementation During Pregnancy: Ocular and Systemic Effects
|
Phase 2 | |
Enrolling by invitation |
NCT06127277 -
Next4You: A Fully Mobile Relationships Based Program for Youth in Foster Care
|
N/A | |
Completed |
NCT05897697 -
Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum Study
|
||
Recruiting |
NCT05899101 -
The Impact of Opioid and Cannabis Exposure on Fetal Growth
|
||
Completed |
NCT05502510 -
Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
|
||
Completed |
NCT04296396 -
Opioid Prescription After Cesarean Trial
|
Phase 3 | |
Not yet recruiting |
NCT06069856 -
Multiple Micronutrient Supplementation (MMS) IFA- Iron Dose Acceptability Crossover Trial
|
Phase 3 | |
Not yet recruiting |
NCT06069869 -
Multiple Micronutrient Supplementation (MMS) Iron Dose Acceptability Crossover Trial
|
Phase 3 | |
Not yet recruiting |
NCT06079918 -
Multiple Micronutrient Supplementation for Maternal Anemia Prevention in Tanzania
|
Phase 3 | |
Not yet recruiting |
NCT06163651 -
Evaluating a One-Year Version of the Parent-Child Assistance Program
|
N/A |